BlossomHill Therapeutics, Inc. carries a market capitalization of 572.61M, placing it among publicly traded companies globally.
| Market Cap | 572.61M |
| Enterprise Value | N/A |
BlossomHill Therapeutics, Inc.'s stock has gained approximately 23.0625% over the past 52 weeks. The 50-day moving average sits at 19.84, while the 200-day moving average is 19.84.
| Beta (5Y) | N/A |
| 52-Week Price Change | 23.0625% |
| 50-Day Moving Average | 19.84 |
| 200-Day Moving Average | 19.84 |
| Average Volume (20 Days) | N/A |